Melanoma risk in Turner syndrome: A case-control study in Surveillance, Epidemiology, and End Results-Medicare

J Am Acad Dermatol. 2024 Oct 10:S0190-9622(24)02961-X. doi: 10.1016/j.jaad.2024.09.055. Online ahead of print.

Authors

Gabriella V Alvarez¹, Kai-Ping Liao¹, Mackenzie R Wehner², Megan N Rogge³

Affiliations

¹ Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX.
² Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX.
³ Department of Dermatology, The University of Texas Health Science Center at Houston, Houston, TX. Electronic address: megan.rogge@uth.tmc.edu.

PMID: 39393551
DOI: 10.1016/j.jaad.2024.09.055

No abstract available

Keywords: Turner syndrome; epidemiology; genodermatoses; melanoma; sex chromosome abnormality.